Health Tip: Managing Hair Loss From Chemotherapy

Source: Cancercompass News: Other Cancer - Category: Cancer & Oncology Source Type: news

Related Links:

SUMMARY OBJECTIVE: To explore the effect of FOLFOX6 chemotherapy on serum vascular endothelial growth factor (VEGF) expression in advanced colorectal cancer patients. METHODS: A retrospective analysis of 81 patients with advanced colorectal cancer who visited our hospital from March 2014 to February 2016 was performed. All the patients were treated with FOLFOX6 chemotherapy. On day 1, patients received oxaliplatin 100 mg/m2 ivgtt (2h), calcium folinate 200 mg/m2 ivgtt (2h), 5 fluorouracil 400 mg/m2 iv bolus and 5 fluorouracil 2500 mg/m2 ivgtt (5h). The treatment course was 2 weeks, and 4 treatment courses were required. Th...
Source: Revista da Associacao Medica Brasileira - Category: General Medicine Source Type: research
Conclusion.PCIA is a common adverse event of breast cancer adjuvant cytotoxic chemotherapy. Clinicians should be aware of this distressing adverse event and develop supportive care strategies to counsel patients and minimize its impact on quality of life.Implications for Practice.Knowledge of permanent chemotherapy‐induced alopecia, an under‐reported adverse event, should lead to optimized pretherapy counseling, anticipatory coping techniques, and potential therapeutic strategies for this sequela of treatment.
Source: The Oncologist - Category: Cancer & Oncology Authors: Tags: Symptom Management and Supportive Care, Breast Cancer Source Type: research
Authors: Daroszewski C, Stasiewicz M, Jaźwińska-Tarnawska E, Rachwalik A, Mura E, Luboch-Kowal J, Dryś A, Bogucki ZA, Brzecka A Abstract The goal of this study was to explore quality of life in patients with advanced non-small-cell lung cancer (NSCLC) in an attempt to single out features that could help predict the possibility of non-completion of chemotherapy. The survey tool was the Quality of Life Questionnaire Core-30 (QLQ-C30) with the module Lung Cancer 13 (LC-13) developed by the European Organization for Research and Treatment of Cancer. The assessment of quality of life (QoL) was performed in 58 patient...
Source: Advances in Experimental Medicine and Biology - Category: Research Tags: Adv Exp Med Biol Source Type: research
ConclusionsConcomitant treatment with RT and nimotuzumab was feasible in an outpatient setting. The PFS and OS were comparable to results achieved with RT and intensive chemotherapy in hospitalized setting.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
AbstractPurposeChemotherapy-induced alopecia (CIA) remains a distressing adverse event of cancer treatment but may be prevented by scalp cooling. The effectiveness of scalp cooling, however, is dependent on the chemotherapy regimen with successful hair preservation (i.e.,
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
ConclusionsThe application of 1% DHL-HisZnNa to the scalp did not prevent CIA. However, this drug may promote recovery from CIA.Trial registration number: UMIN000014840.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
Skin toxicity is a common problem not only when treating breast cancer but in all cancer types. Visible on the surface, these side effects come not just with burdening symptoms but also with stigmatization. With increasing diversity in therapeutic options, dermatologic side effects are also becoming increasingly complex and more challenging for the clinician. We reviewed the most common dermatologic side effects of current anticancer therapy, including toxicity induced by chemotherapy, targeted therapy, and immunotherapy. In particular, we focus on xerosis and pruritus, (acneiform) exanthema, hand-foot syndrome, nail toxic...
Source: Breast Care - Category: Cancer & Oncology Source Type: research
Chemotherapy-induced alopecia has been well documented as a cause of distress to patients undergoing cancer treatment. Almost all traditional chemotherapeutic agents cause severe alopecia. Despite advances in ...
Source: BMC Cancer - Category: Cancer & Oncology Authors: Tags: Research article Source Type: research
Four months ago I was diagnosed with breast cancer. Since then, I’ve had biopsies, a mastectomy, lymph node removals, countless scans and blood tests, an imminent death scare and two rounds of chemotherapy. Today, I’ll be having my third round and by rights I should be feeling terrified. Chemo’s pretty toxic – my oncologist told me semi-jokingly that the aim is to get as close to killing me as possible. But I don’t feel scared – I’m feeling calm and secure. This is because, thanks to the NHS team at south London’s St George’s hospital, a trip to the chemo ward feels as ...
Source: UNISON Health care news - Category: UK Health Authors: Tags: Article Magazine cancer NHS Source Type: news
(American Chemical Society) Although chemotherapy can kill cancer cells very effectively, healthy cells also suffer. If doctors could remove excess chemotherapy drugs from a patient's bloodstream after the medicines have done their job, they might reduce side effects such as hair loss and nausea. Now, researchers have developed a 3D-printed device that absorbs excess chemo drugs before they spread throughout the body. They report their results in ACS Central Science.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Alopecia | Cancer | Cancer & Oncology | Chemotherapy